MHMahya Hekmat

Mahya Hekmat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mahya Hekmat has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Presentation of a case of chest pain leading to coronary artery bypass grafting (CABG) following the third dose of COVID-19 vaccination and an overview of the possible causes of chest pain after COVID-19 vaccination

    by Manouchehr Hekmat, Hamid Ghaderi, Zahra Ansari Aval, Naser Kachoueian, Mahya Hekmat, Roshanak Tirdad, Seyedeh Adeleh Mirjafari

    In the wake of widespread COVID-19 vaccinations, a variety of complications have been reported. Among these, cardiac ischemia stands out as a rare, but significant and potentially dangerous complication, which can progress to myocardial infarction and pose a serious threat to one’s life. Our patient was a 54-year-old man with no risk factors, who developed chest pain five days after the third dose of the COVID-19 vaccine. Notably, he exhibited no symptoms after the first and second doses. For four months, the patient’s symptoms were attributed to inflammatory complications, such as pericarditis and myocarditis, as well as gastrointestinal problems. During this period, he received symptomatic treatment. Due to the persistence of symptoms, heart examinations were conducted, which revealed a constriction at the end of the left main coronary artery. Consequently, the patient underwent coronary artery bypass grafting (CABG). Following cardiac revascularization, the patient’s symptoms were successfully alleviated. Furthermore, his cardiac symptoms were successfully resolved during a six-month follow-up period. The mechanism through which asymptomatic plaques in the coronary vessels are activated following the COVID-19 vaccination or infection remains unclear. Regardless of the cause, any chest discomfort experienced after COVID-19 vaccination or infection should be treated with utmost seriousness, and examinations for acute coronary syndrome should be conducted.

  • Open Access

    Introducing a very rare case of intra-pericardial thyroid tissue with blood supply from the aortic arch in a patient with renal cell carcinoma: A case report and review of the literature

    by Manouchehr Hekmat, Hamid Ghaderi, Mahya Hekmat, Zahra Ansari Aval, Seyedeh Adeleh Mirjafari, Roshanak Tirdad

    Intra-pericardial heterotopic thyroid (IPHT) is an incidental finding during open-heart surgery. Although heterotopic thyroid has been reported in different parts of the body, only a few cases of intra-pericardium have been reported so far. In most articles, intracardiac, intrathoracic and heterotopic thymus cases are mistakenly included as IPTH cases A 57-year-old man with a history of non-Hodgkin lymphoma, who was treated 8 years ago and recovered, is now a candidate for surgery due to clear cell renal carcinoma in the left kidney with inferior vena cava (IVC) thrombus tumor that has spread into the right atrium. At the same time, he was operated on by two teams of urology and heart surgery. The patient’s kidney was removed, and then he was subjected to sternotomy by the heart surgery team to remove the thrombus tumor. After opening the pericardium inside the pericardial cavity, a pericardial mass measuring 1×2 ×3 cm, which was connected to the lower surface of the aortic arch by a 1 cm long stalk, was observed. It was resected and sent to pathology laboratory. The rest of the surgery to remove the thrombus tumor from inside the right atrium and IVC continued according to the procedure. The pathological report was benign thyroid tissue. Actual cases of IPTH are underreported, and due to the small number, it is not yet possible to comment on the prevalence of malignancy in it or its functional role; However any lesion or abnormal mass in the pericardial cavity should be respected and sent to pathology laboratory therefore by collecting information about these masses, in the future, decisions can be made and summarized.

  • Open Access

    Does the exhaust air from oxygenator during open-heart surgeries in COVID-19 positive patients cause operating room air contamination? A case report

    by Manouchehr Hekmat, Hamid Ghaderi, Zahra Ansari Aval, Seyedeh Adeleh Mirjafari, Mahya Hekmat

    Introduction: New findings regarding Covid 19 are reviewed and reported daily, and safety protocols are changed regularly. In Covid positive patients, the exhaust air coming from oxygenator’s gas outlet may be a potential source of air contamination in operating room. This may also cause health issues for Operating room staff. As there has been no research regarding this issue, this study will reveal whether the exhaust air from the oxygenator in Covid positive patient may cause air contamination or not. Case presentation: The Covid positive patient underwent emergency cardiopulmonary bypass. After surgery, PCR swab was taken from the oxygenator exhaust, which evacuate the air inside the oxygenator into the operating room theatre. The positive PCR test for Covid may suggests the possibility of air contamination by oxygenator. Result: This may be the first study suggesting the possibility of room air contamination by oxygenator exhaust air during cardiopulmonary bypass. This study shows some current protocols may need to be reviewed in order to ensure increased safety within the operating room and amongst the personnel, therefore permanent changes may be applied to some procedures.